Effects of Hydrolysed Porcine Proteins on Muscle Protein Synthesis and Appetite
NCT ID: NCT02477410
Last Updated: 2017-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2015-07-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is hypothesised that hydrolysed porcine proteins will stimulate muscle protein synthesis, affect appetite and the secretion of gastrointestinal hormones similar to hydrolysed whey protein.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective Appetite
NCT01677273
Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects
NCT00809874
Investigating the Consumption of Different Protein Rich Whole Food Sources on Muscle Growth in Trained Males and Females
NCT04794153
Insect Protein and Muscle Protein Signaling
NCT04633694
Influence of Carbohydrate on Amino Acid Absorption From Dietary Protein (ICADP)
NCT03303729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will be conducted as a randomised, 3-way, cross-over study. It consists of three visits separated by at least two weeks. It is expected that 18 normal-weight, young men will complete the study. They will be randomised to the order of the three proteins; hydrolysed porcine protein from blood (HPB), hydrolysed porcine protein from muscle (HPM) and hydrolysed whey protein (HW). At each visit the effects on muscle protein synthesis, appetite and secretion of gastrointestinal hormones will be measured/assessed. Muscle protein synthesis will be measured after consumption of a low (15 g) and a high (30 g) dose of protein and appetite and secretion of gastrointestinal hormones will be measured after the high protein dose (30 g). The effect on muscle protein synthesis will be measured by a flood-primed continuous infusion of labelled (Ring13C6) phenylalanine, muscle biopsies and blood samples. The effects on appetite will be assessed by visual analogue scales, an ad libitum meal and blood samples.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hydrolysed porcine protein from blood
Dietary intervention with hydrolysed porcine protein from blood
Hydrolysed porcine protein from blood
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Hydrolysed porcine protein from muscle
Dietary intervention with hydrolysed porcine protein from muscle
Hydrolysed porcine protein from muscle
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Hydrolysed whey protein
Dietary intervention with hydrolysed whey protein
Hydrolysed whey protein
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrolysed porcine protein from blood
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Hydrolysed porcine protein from muscle
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Hydrolysed whey protein
Effects of hydrolysed porcine proteins on muscle protein synthesis and appetite
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal weight (BMI 18.5-25 kg/m2)
* 22-40 years
Exclusion Criteria
* Weight change \>3kg within 2 months prior to start of the study
* Regular participation in cardio/strength training within 6 months prior to (and during) the study (\>1 per wk)
* Use of alcohol \>14 drinks/wk
* Drug abuse
* Smoking
* Regular consumption of protein supplements
* Use of over-the-counter or prescription medication that influences body weight, appetite or metabolism
* Diabetes Mellitus
* Dyslipidemia
* Diseases, which influence metabolism
* Donation of blood 3 months prior to start of (and during) the study
* Subjects with a hemoglobin value \< 8 mol/L (measured at screening)
* Participation in other clinical studies 1 month prior to start of (and during) the study
* Subjects who are unable to give an informed consent.
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Svineafgiftsfonden
UNKNOWN
DC Ingredients
UNKNOWN
Arla Food Ingredients Group P/S
UNKNOWN
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arne Astrup
Prof., DM. DMSc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arne Astrup, DMSc
Role: PRINCIPAL_INVESTIGATOR
Department of Nutrition, Exercise and sports, University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition, Exercise and Sports
Frederiksberg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-15003581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.